Who’s going to run Biogen? Does Aduhelm have a future? And is it OK to shame reporters?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We delve into Biogen’s twin announcements that the company is pulling the plug on Aduhelm and replacing its embattled CEO, discussing the future of Alzheimer’s disease and just who might want to lead the company. We also explain the latest on Covid-19 vaccines, a strange situation for Vertex Pharmaceuticals, and the controversy surrounding the White House Correspondents’ Dinner.
For more on what we cover, here’s the news on Biogen; here’s more on its CEO succession; here’s the latest from Moderna; here’s the news on Vertex; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].
Create a display name to comment
This name will appear with your comment